Abstract
Background
Alkylphosphocholines (APCs) are synthetic phospholipid derivatives, and have been demonstrated to inhibit ocular cell proliferation in vitro and in vivo. Currently, they are applied clinically for their antitumoral and antiparasitic properties, but have not yet been implemented for clinical use in proliferative ophthalmic disorders. The purpose of this study was to assess the safety of APC in the ex vivo model of the isolated perfused vertebrate retina.
Methods
Bovine retina preparations were perfused with an oxygen pre-equilibrated standard solution. The electroretinogram (ERG) was recorded using Ag/AgCl-electrodes. After recording stable b-wave amplitudes, an APC was applied at the following concentrations to the nutrient solution: 0.25 µM, 2.5 µM and 25 µM. To investigate the effects of APC on photoreceptor function, a test series at the same concentrations was performed to evaluate the effects of APC on the a-wave amplitude. Aspartate at a concentration of 1 mM was added to the nutrient solution to obtain stable a-wave amplitudes. Thereafter, APC was applied at the same concentrations to the nutrient solution. The recovery of the ERG amplitudes was followed up for 75 minutes.
Results
No reduction of the a- and b-wave amplitude was found at the end of the exposure time with APC added in each test series. No differences were found between the ERG amplitudes before and after application of APC at the end of the washout.
Conclusions
In the ex vivo model of the isolated perfused vertebrate retina, APC has proved to be a safe compound in the concentrations applied. Thus, APCs should further be considered as promising candidates for future clinical applications in ophthalmology.
Similar content being viewed by others
References
Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M, Mansi J (2001) Randomized, double-blind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol 19:4150–4159
Sundar S, Jha TK, Thakur CP, Engel J, Sindermann H, Fischer C, Junge K, Bryceson A, Berman J (2002) Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 347:1739–1746
Eibl KH, Banas B, Kook D, Ohlmann AV, Priglinger S, Kampik A, Welge-Luessen UC (2004) Alkylphosphocholines: a new therapeutic option in glaucoma filtration surgery. Invest Ophthalmol Vis Sci 45:2619–2624
Eibl KH, Liegl R, Kernt M, Priglinger S, Kampik A (2009) Alkylphosphocholines as possible inhibitors of posterior capsule opacification after cataract surgery. J Cataract Refract Surg 35:900–905
Eibl KH, Banas B, Schoenfeld CL, Neubauer AS, Priglinger S, Kampik A, Welge-Luessen U (2003) Alkylphosphocholines inhibit proliferation of human retinal pigment epithelium. Invest Ophthalmol Vis Sci 44:3556–3561
Eibl KH, Kook D, Priglinger S, Haritoglou C, Kampik A, Welge-Luessen U (2006) Human retinal pigment epithelial cell attachment, spreading and migration inhibition by alkylphosphocholines. Invest Ophthalmol Vis Sci 47:364–370
Eibl KH, Schwabe K, Welge-Luessen U, Kampik A, Eichler W (2008) The role of alkylphosphocholines in retinal Müller glial cell proliferation. Curr Eye Res 33:385–393
Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC (1981) Epiretinal and vitreous membranes. Comparative study of 56 cases. Arch Ophthalmol 99:1445–1454
Kirchhof B (2004) Strategies to influence PVR development. Graefes Arch Clin Exp Ophthalmol 242:699–703
Fisher SK, Lewis GP, Linberg KA, Verardo MR (2005) Cellular remodeling in mammalial retina: results from studies of experimental retinal detachment. Prog Retin Eye Res 24:395–431
Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH (2004) Bunce C; PVR Study Group. A randomised controlled trial of combined 5-fluouracil and low-molecular weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 111:2240–2245
Eibl KH, Lewis GP, Betts K, Linberg KA, Gandorfer A, Fisher SK, Kampik A (2007) Possible role of alkylphosphocholines in retinal reattachment surgery. Ophthalmologe 104:972–977
Eibl KH, Lewis GP, Betts K, Linberg KA, Gandorfer A, Kampik A, Fisher SK (2007) The effect of alkylphosphocholines on intraretinal proliferation initiated by experimental retinal detachment. Invest Ophthalmol Vis Sci 48:1305–1311
Schuettauf F, Eibl KH, Thaler S, Shinoda K, Rejdak R, May CA, Blatsios G, Welge-Luessen U (2005) Toxicity study of erucylphosphocholine in a rat model. Curr Eye Res 30:813–820
Sickel W (1965) Respiratory and electrical responses to light stimulation in the retina of the frog. Science 148:648–651
Lüke M, Krott R, Warga M, Szurmann P, Grisanti S, Bartz-Schmidt KU, Schneider T, Lüke C (2007) Effects of the protein tyrosine kinase inhibitor genistein and taurine on retinal function in isolated superfused retina. Graefes Arch Clin Exp Ophthalmol 245:242–248
Hueber A, Lüke M, Esser PJ, Kirchhof B, Sickel W, Lüke C (2005) Effects of daunorubicin and CD95L on retinal function in superfused vertebrate retina. J Ocul Pharmacol Ther 21:133–138
Lüke M, Januschowski K, Beutel J, Warga M, Grisanti S, Peters S, Schneider T, Lüke C, Bartz-Schmidt KU, Szurman P (2008) The effects of triamcinolone crystals on retinal function in a model of isolated perfused vertebrate retina. Exp Eye Res 87:22–29
Lüke M, Weiergräber M, Brand C, Siapich SA, Banat M, Hescheler J, Lüke C, Schneider T (2005) The isolated perfused bovine retina—a sensitive tool for pharmacological research on retinal function. Brain Res Brain Res Protoc 16:27–36
Cai J, Wei R, Ma X, Zhu H, Li Y (2001) Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro. Int Ophthalmol 24:225–231
Levy J, Tesller Z, Rosenthal G, Klemperer I, Zirkin HJ, Kachko L, Lifshitz T (2001) Toxic effects of subkonjunctival 5-fluouracil and mitomycin C on ciliary body of rats. Int Ophthalmol 24:199–203
Lattanzio FA Jr, Sheppard JD Jr, Allen RC, Baynham S, Samuel P, Samudre S (2005) Do injections of 5-fluorouracil after trabeculectomy have toxic effects on the anterior segment? J Ocul Pharmacol Ther 21:223–235
Chang SW (2005) Corneal keratocyte apoptosis following topical intraoperative mitomycin C in rabbits. J Refract Surg 21:446–453
Palanca-Capistrano AM, Hall J, Cantor LB, Morgan L, Hoop J, WuDunn D (2009) Long-term outcomes of intraoperative 5-fluouracil versus intraoperative mitomycin C in primary trabeculectomy surgery. Ophthalmology 116:185–190
Abdelwahab MT, Kugelberg M, Seregard S, Zetterström C (2007) Safety of irrigation with 5-fluouracil in a sealed-capsule irrigation device in the rabbit eye. J Cataract Refract Surg 33:1619–1623
Wiedemann P, Hilgers RD, Bauer P, Heimann K (1998) Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 126:550–559
Szurmann P, Sierra A, Kaczmarek R, Jaissle GB, Wallefels-Thilo B, Grisanti S, Lüke M, Bartz-Schmidt KU, Spitzer MS (2007) Different biocompatibility of crystalline triamcinolone deposits on retinal cells in vitro and in vivo. Exp Eye Res 85:44–53
Author information
Authors and Affiliations
Corresponding author
Additional information
Matthias Lüke and Kai Januschowski contributed equally.
Rights and permissions
About this article
Cite this article
Lüke, M., Januschowski, K., Lüke, J. et al. The safety profile of alkylphosphocholines in the model of the isolated perfused vertebrate retina. Graefes Arch Clin Exp Ophthalmol 248, 511–518 (2010). https://doi.org/10.1007/s00417-009-1246-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-009-1246-8